Short-circuiting autoimmune disease by target-tissue-derived nitric oxide

Yvonne R. Garcia, Keith A. Krolick

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


A previous report from this laboratory suggested that expression of skeletal-muscle-derived, inducible nitric oxide synthase (iNOS), is associated with resistance to the autoimmune model of myasthenia gravis (MG) demonstrated by Wistar Furth rats following the passive transfer of antibody reactive with the nicotinic acetylcholine receptor (AChR). The study reported below demonstrates an association between increased expression of iNOS/NO in Wistar Furth rats and the induction of programmed cell death (apoptosis) in both macrophages and CD4+ T cells that attempt to traffic through targeted muscles. It is concluded that production of muscle-derived NO is protective in experimental MG, and in part, dictates the severity of eventual immunopathology.

Original languageEnglish (US)
Pages (from-to)74-80
Number of pages7
JournalClinical Immunology
Issue number1
StatePublished - Oct 2004


  • Autoimmune disease
  • Muscle disease
  • Myasthenia gravis
  • Nitric oxide
  • iNOS

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Short-circuiting autoimmune disease by target-tissue-derived nitric oxide'. Together they form a unique fingerprint.

Cite this